Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol.
— Sachs Associates (@SachsAssociates) February 2, 2022
e-Meet @ActinogenMed at #Sachs_ELSF
More info @ https://t.co/b7zJA2j8ns pic.twitter.com/dOnTAvBYbc